Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Depression and Enhancement of Cognitive Recovery Following Traumatic Brain Injury With Duloxetine

NCT01223001 is registered in ClinicalTrials.gov with Rehabilitation Hospital of Indiana as lead sponsor.

NCT NCT01223001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01223001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Depression and Enhancement of Cognitive Recovery Following Traumatic Brain Injury With Duloxetine
Lead sponsor
Rehabilitation Hospital of Indiana
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 1996
Completion date
July 31, 2011
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, traumatic brain injury